This week on MIP: DABUS endgame, litigation funder battle

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

This week on MIP: DABUS endgame, litigation funder battle

Generative AI.jpeg

We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP

AI can’t invent, UK Supreme Court rules

The UK Supreme Court ruled unanimously that only people, not artificial intelligence tools, can be named as inventors under UK patent law.

The keenly awaited decision, on Wednesday, December 20, was a final defeat for the legal team behind the so-called DABUS case that sought to establish an AI tool as the inventor of a food storage system.

Click here to read more

Lawyers battle over litigation funder’s role in Microsoft patent dispute

A lawyer has asked to withdraw from a patent dispute involving Microsoft, citing a conflict with a litigation funder and allegedly unpaid fees.

William Ramey, a lawyer at Ramey LLP, filed a motion at the Court of Appeals for the Federal Circuit in which he asked to withdraw himself from CTD Networks v Microsoft.

Click here to read more

Other articles published by Managing IP this week include:

UK govt: AI inventorship reform must be global

Weekly take: Why 2023 was a mixed bag for the IP legal market

The IP Lounge: The top 50 in IP 2023, year in review

Five minutes with … Hiroyuki Hagiwara, Paul Hastings

Sources: IP lawyers well-placed to handle China’s diminishing judicial transparency

Behind the case: How Hungry Jack’s overcame TM beef over burger names

Elsewhere in IP

Watch stopped

Apple paused sales of some smart watches on Monday, December 18, amid a high-profile patent infringement row with medical technology company Masimo.

The US International Trade Commission imposed an import ban on the watches earlier this year after Apple was found to have infringed Masimo’s patents.

But that decision is subject to a potential veto by President Joe Biden, who has until December 25 to decide whether the ban should stand.

Apple said it was pausing sales of the allegedly infringing Apple Watch models as a pre-emptive measure.

Fantasy lawsuit

Amazon and the estate of fantasy writer JRR Tolkien have won a US copyright suit brought by the author of a so-called “sequel” to ‘Lord of the Rings’.

Demetrious Polychron filed the suit at the District Court for the District of California, claiming that Amazon’s “The Rings of Power” series copied his book “The Fellowship of the King”.

But Polychron’s complaint backfired when the Tolkien estate filed a countersuit for copyright infringement.

Judge Steven Wilson awarded Amazon and the Tolkien family $134,637 in attorney’s fees after finding Polychron’s suit was “frivolous from the beginning”.

SPC refusal

Merck has missed out on a supplementary protection certificate for multiple sclerosis drug cladribine after a defeat at the England and Wales High Court on Tuesday, December 19.

The UKIPO refused to grant the SPC for the drug, for which the patent will expire in December 2025, after finding Merck didn’t qualify under the Court of Justice of the EU’s Santen decision, issued in 2020.

Merck argued that it developed its cladribine product with the “legitimate expectation” that it would be entitled to an SPC under Neurim, an earlier CJEU decision from 2012.

But King's counsel Michael Tappin, sitting as a deputy high court judge, criticised this argument.

Price tag

The Unified Patent Court’s Munich Local Division refused to grant a preliminary injunction in a lawsuit over patents covering electronic price tags on Wednesday, December 20.

Judge Matthias Zigann said the court wasn’t satisfied that electronics company SES-imagotag’s patent was infringed by competitor Hanshow Technology.

The written order has yet to be published.

That's it for 2023, see you again next year. We wish you all a happy festive period and new year.

more from across site and SHARED ros bottom lb

More from across our site

Bird & Bird helps GSK score a major injunction as the battle to become the UPC’s busiest division tightens, and overall filings reach a new monthly high
CEO Annette Bach explains how the Danish IP consultancy plans to build on its 65% profit growth while keeping external investment off the table for now
Belgian attorneys have revived fax systems to protect clients’ filing rights, while uncertainty over exposed patent data has left firms struggling to answer questions about the breach
In his first interview since leaving Weil Gotshal & Manges, Chris Henry explains why he returned to Latham and how he plans to bolster its tech disputes offering
As GTA VI underlines the extraordinary value of gaming franchises, lawyers at Clifford Chance say investors need to know the IP behind their next deal can deliver the growth they are paying for
As ‘big law’ invests in IP litigation, trial firms are emerging as a valuable source of seasoned courtroom talent
Six hires across the IP spectrum reflect Orrick’s efforts to better serve tech clients across the IP lifecycle
David Stone, partner at White & Case, argues that the government’s planned reforms will modernise and futureproof UK design law, but leave two of the thorniest problems unresolved
Max Scott will join the firm’s IP transactions group in California, becoming the latest Weil IP partner to secure their future
Yonatan Drori, attorney at Drori-Stav IP in Israel, explains why foreign counsel must treat Israel’s patent disclosure requirements as an ongoing obligation, rather than a one-off formality
Gift this article